Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Recurrent Moderate-Severe Chronic Graft Versus Host Disease

Tundra lists 1 Recurrent Moderate-Severe Chronic Graft Versus Host Disease clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT04198922

Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

This phase II trial studies how well acalabrutinib works in treating patients with chronic graft versus host disease. Acalabrutinib may be an effective treatment for graft-versus-host disease caused by a stem cell transplant.

Gender: All

Ages: 18 Years - Any

Updated: 2025-11-05

6 states

Recurrent Moderate-Severe Chronic Graft Versus Host Disease

Hematopoietic and Lymphoid Cell Neoplasm